OSCA vs. Placebo: How Stem Cell Treatment for Knee Pain is Changing Lives
AI 요약 정보
- Kangstem reports Phase 2a results from 113 patients
- OSCA pain/function gains vs placebo significant at 24 weeks
- MRI shows mid-dose MOCART score gains; more trials needed
